JPS5386035U - - Google Patents
Info
- Publication number
- JPS5386035U JPS5386035U JP17072676U JP17072676U JPS5386035U JP S5386035 U JPS5386035 U JP S5386035U JP 17072676 U JP17072676 U JP 17072676U JP 17072676 U JP17072676 U JP 17072676U JP S5386035 U JPS5386035 U JP S5386035U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17072676U JPS5386035U (enrdf_load_html_response) | 1976-12-16 | 1976-12-16 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17072676U JPS5386035U (enrdf_load_html_response) | 1976-12-16 | 1976-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5386035U true JPS5386035U (enrdf_load_html_response) | 1978-07-15 |
Family
ID=28778266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17072676U Pending JPS5386035U (enrdf_load_html_response) | 1976-12-16 | 1976-12-16 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5386035U (enrdf_load_html_response) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
| US6960474B2 (en) | 2000-06-28 | 2005-11-01 | Bristol-Myers Squibb Company | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator |
| US7001911B2 (en) | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
| US7141578B2 (en) | 2000-09-19 | 2006-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7291637B2 (en) | 2001-12-19 | 2007-11-06 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
-
1976
- 1976-12-16 JP JP17072676U patent/JPS5386035U/ja active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960474B2 (en) | 2000-06-28 | 2005-11-01 | Bristol-Myers Squibb Company | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator |
| US7001911B2 (en) | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
| US7432267B2 (en) | 2000-06-28 | 2008-10-07 | Bristol-Myers Squibb Comapny | Fused cyclic modulators of nuclear hormone receptor function |
| US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
| US7141578B2 (en) | 2000-09-19 | 2006-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7517904B2 (en) | 2000-09-19 | 2009-04-14 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7470797B2 (en) | 2001-06-20 | 2008-12-30 | Bristol-Myers Squibb Company | Fused heterocyclic imido and amido compounds |
| US7291637B2 (en) | 2001-12-19 | 2007-11-06 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7342034B2 (en) | 2001-12-19 | 2008-03-11 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |